Astrotech (DE) (ASTC) vs Nautilus Biotechnology (NAUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nautilus Biotechnology (NAUT) has outperformed Astrotech (DE) (ASTC) over the past year, gaining 126.3% versus a gain of 36.9%. Over five years, NAUT leads with a -65.7% price change compared with -76.7% for ASTC. Nautilus Biotechnology is the larger company by market cap ($239.2 million vs $14.6 million), about 16.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTC | NAUT |
|---|---|---|
| Share price | $6.95 | $1.88 |
| Market cap | $14.59M | $239.24M |
| 1-day change | +1.24% | -4.09% |
| YTD return | +98.27% | +0.51% |
| 1-year return | +36.93% | +126.33% |
| 5-year return | -76.67% | -65.67% |
| EPS (TTM) | $-8.49 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $68.85 | $4.31 |
| 52-week low | $1.92 | $0.82 |
| Distance from 52-week high | -89.91% | -56.38% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +103.72% |
| Average volume | 130.50K | 2.59M |
| Shares outstanding | 2.10M | 127.26M |
| Employees | — | 127 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nautilus Biotechnology is about 16.4 times larger than Astrotech (DE) by market value ($239.24M vs $14.59M).
- NAUT has outperformed ASTC by 89.4 percentage points over the past year.
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
ASTC vs NAUT FAQ
Which is bigger, Astrotech (DE) or Nautilus Biotechnology?
Nautilus Biotechnology (NAUT) is larger, with a market capitalization of $239.24M compared with $14.59M for Astrotech (DE) (ASTC).
Which stock has performed better over the past year, ASTC or NAUT?
NAUT returned +126.33% over the past 12 months, compared with +36.93% for ASTC (price return, excluding dividends). Past performance does not predict future results.
Are Astrotech (DE) and Nautilus Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.